Common Stock, Shares, Outstanding of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 3.97B shares, a 137% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 3.97B +2.3B +137% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 2.98B +1.62B +119% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 1.67B +447M +36.5% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 1.36B +544M +66.7% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 1.22B +409M +50.1% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 816M 0 0% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 816M +300M +58.2% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 816M +352M +75.9% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 516M +104M +25.4% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 464M +343M +284% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 411M 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 121M +80.3M +199% 31 Dec 2019 20-F 25 Mar 2021
Q4 2018 40.4M 31 Dec 2018 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.